Harvard Bioscience Inc (HBIO)
2.26
+0.10
(+4.63%)
USD |
NASDAQ |
Nov 22, 16:00
2.26
0.00 (0.00%)
After-Hours: 16:10
Harvard Bioscience Total Liabilities (Quarterly): 65.92M for Sept. 30, 2024
Total Liabilities (Quarterly) Chart
Historical Total Liabilities (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2024 | 65.92M |
| June 30, 2024 | 61.66M |
| March 31, 2024 | 64.35M |
| December 31, 2023 | 64.29M |
| September 30, 2023 | 65.45M |
| June 30, 2023 | 67.51M |
| March 31, 2023 | 71.24M |
| December 31, 2022 | 73.14M |
| September 30, 2022 | 75.03M |
| June 30, 2022 | 77.77M |
| March 31, 2022 | 81.67M |
| December 31, 2021 | 78.94M |
| September 30, 2021 | 76.98M |
| June 30, 2021 | 75.27M |
| March 31, 2021 | 74.13M |
| December 31, 2020 | 79.57M |
| September 30, 2020 | 72.45M |
| June 30, 2020 | 74.62M |
| March 31, 2020 | 80.25M |
| December 31, 2019 | 83.18M |
| September 30, 2019 | 85.67M |
| June 30, 2019 | 85.91M |
| March 31, 2019 | 90.99M |
| December 31, 2018 | 85.89M |
| September 30, 2018 | 84.08M |
| Date | Value |
|---|---|
| June 30, 2018 | 88.04M |
| March 31, 2018 | 91.65M |
| December 31, 2017 | 28.45M |
| September 30, 2017 | 33.77M |
| June 30, 2017 | 33.65M |
| March 31, 2017 | 34.68M |
| December 31, 2016 | 35.57M |
| September 30, 2016 | 36.28M |
| June 30, 2016 | 37.42M |
| March 31, 2016 | 39.68M |
| December 31, 2015 | 42.45M |
| September 30, 2015 | 39.27M |
| June 30, 2015 | 43.76M |
| March 31, 2015 | 43.62M |
| December 31, 2014 | 40.45M |
| September 30, 2014 | 39.35M |
| June 30, 2014 | 39.48M |
| March 31, 2014 | 39.11M |
| December 31, 2013 | 40.98M |
| September 30, 2013 | 40.50M |
| June 30, 2013 | 40.67M |
| March 31, 2013 | 31.06M |
| December 31, 2012 | 29.27M |
| September 30, 2012 | 30.22M |
| June 30, 2012 | 31.52M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
61.66M
Minimum
Jun 2024
83.18M
Maximum
Dec 2019
73.17M
Average
74.38M
Median
Total Liabilities (Quarterly) Benchmarks
| Bruker Corp | 4.270B |
| Azenta Inc | 331.07M |
| Bionano Genomics Inc | 38.49M |
| Akoya Biosciences Inc | 116.34M |
| Singular Genomics Systems Inc | 63.30M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 131.24M |
| Shareholders Equity (Quarterly) | 65.32M |
| Debt to Equity Ratio | 0.5796 |
| Current Ratio | 2.057 |
| Net Debt Paydown Yield | 0.61% |